Načítá se...
Considering race and the potential for ERG expression as a biomarker for prostate cancer
Genomic rearrangement and overexpression of the ERG oncogene (also known as v-ets avian erythroblastosis virus E26 oncogene homolog) is estimated to occur at a rate of 40–50% in prostate cancer. Early evidence suggests that ERG overexpression may be associated with disease progression, and the utili...
Uloženo v:
| Vydáno v: | Per Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4276316/ https://ncbi.nlm.nih.gov/pubmed/25544850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme.14.26 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|